IBOC(IBOC)
IBOC
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $1.21B | $1.39B | $1.60B | $1.84B | $2.11B |
| Low | $1.21B | $1.39B | $1.60B | $1.84B | $2.11B |
| High | $1.21B | $1.39B | $1.60B | $1.84B | $2.11B |
| EBITDA Avg | $657M | $755M | $867M | $996M | $1.14B |
| Low | $657M | $755M | $867M | $996M | $1.14B |
| High | $657M | $755M | $867M | $996M | $1.14B |
| EBIT Avg | $624M | $717M | $823M | $946M | $1.09B |
| Low | $624M | $717M | $823M | $946M | $1.09B |
| High | $624M | $717M | $823M | $946M | $1.09B |
| Net Income Avg | $398M | $420M | $451M | $446M | $446M |
| Low | $398M | $420M | $451M | $446M | $446M |
| High | $398M | $420M | $451M | $446M | $446M |
| EPS Avg | $6.39 | $6.75 | $7.25 | $7.17 | $7.17 |
| Low | $6.39 | $6.75 | $7.25 | $7.17 | $7.17 |
| High | $6.39 | $6.75 | $7.25 | $7.17 | $7.17 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|---|
| Revenue Avg | $273M | $283M | $293M | $303M |
| Low | $273M | $283M | $293M | $303M |
| High | $273M | $283M | $293M | $303M |
| EBITDA Avg | $148M | $154M | $159M | $165M |
| Low | $148M | $154M | $159M | $165M |
| High | $148M | $154M | $159M | $165M |
| EBIT Avg | $141M | $146M | $151M | $156M |
| Low | $141M | $146M | $151M | $156M |
| High | $141M | $146M | $151M | $156M |
| Net Income Avg | $98M | $101M | $101M | $103M |
| Low | $98M | $101M | $101M | $103M |
| High | $98M | $101M | $101M | $103M |
| EPS Avg | $1.58 | $1.63 | $1.62 | $1.66 |
| Low | $1.58 | $1.63 | $1.62 | $1.66 |
| High | $1.58 | $1.63 | $1.62 | $1.66 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |